Personalis, Inc., a leader in advanced genomics for cancer, today announced that the company will present one oral presentation and five posters at the American Association for Cancer Research (AACR) Annual Meeting being held this year in Atlanta, GA from March 31 “ April 3, 2019.
Personalis presentations will highlight how fundamental oncology research informs the ongoing evolution of our leading immunogenomics analysis platform. The presentations will also detail the alignment between our genomics solutions and AACR’s 2019 theme: Integrative Cancer Science ¢ Global Impact ¢ Individualized Patient Care.
Following is a list of abstracts that will be presented at the meeting.
|Presentation #||Title & Presenter||Day & Time||Location|
|MS.BSB01.01 905 (Oral Presentation)||March 31 3:05 pm-3:20 pm||Room B206|
|PO.MCB09.04 2512 / 8|
WANT TO BUILD A FINANCIAL EMPIRE?
Subscribe to the Global Banking & Finance Review Newsletter for FREE Get Access to Exclusive Reports to Save Time & Money
By using this form you agree with the storage and handling of your data by this website. We Will Not Spam, Rent, or Sell Your Information.
|April 1 1-5pm||Poster section 33|
|PO.BSB01.01 3377/8||April 2 8 am-12 pm||Poster section 31|
|PO.TB11.02 3788 / 5||April 2 1 pm-5 pm||Poster section 8|
|PO.CH03.01 4536 / 9||April 3 8 am-12 pm||Poster section 2|
|PO.TB10.03 4695 / 8||April 3 8 am-12 pm||Poster section 9|
About Personalis, Inc.
Personalis, Inc. is a growing cancer genomics company transforming the development of next-generation therapies by providing more comprehensive molecular data about each patients cancer and immune response. The companys NeXT Platform is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, from a single sample. The Personalis Clinical Laboratory is GxP aligned as well as CLIA88-certified and CAP-accredited. For more information, please visit www.personalis.com and follow Personalis on Twitter (@PersonalisInc).